Cardiology
Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry
Hyun-Jin Kim, Jeong-Hun Shin, Yonggu Lee, Ju Han Kim, Sun Ho Hwang, Woo Shik Kim, Sungha Park, Sang Jae Rhee, Eun Mi Lee, Sang Hyun Ihm, Wook Bum Pyun, Jinho Shin
Korean J Intern Med. 2021;36(5):1102-1114. Published online June 18, 2021
Background/Aims: The clinical characteristics of patients with masked uncontrolled hypertension (MUCH) have been poorly defined, and few studies have investigated the clinical predictors of MUCH. We investigated the demographic, clinical, and blood pressure (BP) characteristics of patients with MUCH..
|
|
24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension
Hae-Young Lee, Cheol-Ho Kim, Jae-Kwan Song, Shung Chull Chae, Myung Ho Jeong, Dong-Soo Kim, Byung-Hee Oh
Korean J Intern Med. 2017;32(6):1025-1036. Published online October 17, 2017
Background/Aims: Fimasartan is an angiotensin type 1 receptor blocker (ARB) which has comparable efficacy and tolerability with other ARBs. The aim of this study was to evaluate 24-hour blood pressure (BP) lowering efficacy and the tolerability of the low dose fimasartan compared with valsartan in p..
|
|
Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group
Jinho Shin, Sung Ha Park, Ju Han Kim, Sang Hyun Ihm, Kwang-il Kim, Woo Shik Kim, Wook Bum Pyun, Yu-Mi Kim, Sung-il Choi, Soon Kil Kim
Korean J Intern Med. 2015;30(5):610-619. Published online August 27, 2015
Background/Aims: The detection of white coat hypertension (WCH), treated normalized hypertension, and masked hypertension (MH) is important to improve the effectiveness of hypertension management. However, whether global cardiovascular risk (GCR) profile has any effect on the discordance between amb..
|
|
|